Royal Bank of Canada
SPRB

Royal Bank of Canada’s Spruce Biosciences SPRB Stock Holding History

Royal Bank of Canada’s Portfolio SPRB Stock Details SPRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8K Buy
+166
New +$9.28K ﹤0.01% 6808
2026
Q1 		– Sell
-40
Closed -$3K – 7881
2025
Q4 		$3K Buy
+40
New +$4.29K ﹤0.01% 6869
2024
Q4 		– Sell
-50
Closed -$2K – 7359
2024
Q3 		$2K Buy
50
+47
+1,567% +$1.72K ﹤0.01% 6673
2024
Q2 		$0 Buy
+3
New +$161 ﹤0.01% 7653
2024
Q1 		– Sell
-119
Closed -$26K – 7728
2023
Q4 		$26K Sell
119
-10
-8% -$1.16K ﹤0.01% 6233
2023
Q3 		$22K Buy
129
+95
+279% +$16K ﹤0.01% 6154
2023
Q2 		$5K Sell
34
-1,218
-97% -$204K ﹤0.01% 6693
2023
Q1 		$208K Buy
+1,252
New +$233K ﹤0.01% 4600
2022
Q4 		– Sell
-1
Closed – – 7832
2022
Q3 		$0 Sell
1
-1
-50% -$140 ﹤0.01% 7969
2022
Q2 		$0 Sell
2
-6
-75% -$769 ﹤0.01% 7804
2022
Q1 		$1K Sell
8
-16
-67% -$2.98K ﹤0.01% 7633
2021
Q4 		$8K Buy
24
+12
+100% +$3.57K ﹤0.01% 7128
2021
Q3 		$5K Buy
12
+4
+50% +$2.51K ﹤0.01% 7153
2021
Q2 		$7K Sell
8
-3
-27% -$3.2K ﹤0.01% 6996
2021
Q1 		$13K Buy
11
+6
+120% +$9.21K ﹤0.01% 6691
2020
Q4 		$8K Buy
+5
New +$8.29K ﹤0.01% 6493

Other funds holding SPRB

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SC
Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return

Royal Bank of Canada's SPRB Position: Q2 2026 in Review

Royal Bank of Canada opened a new position in Spruce Biosciences (SPRB) in Q2 2026: 166 shares worth $8K. The stake represents ﹤0.01% of the portfolio and ranks #6808 among its holdings. This is a return to the name: Royal Bank of Canada previously reported a position in SPRB as recently as Q4 2025.

Royal Bank of Canada first reported a position in SPRB in Q4 2020 and has held it in 16 quarters since. The position peaked at $208K in Q1 2023. 57 funds tracked by Wall St. Rank hold SPRB as of Q2 2026.

  • Royal Bank of Canada held 166 shares of Spruce Biosciences worth $8K as of Q2 2026.
  • Spruce Biosciences was a new Royal Bank of Canada position in Q2 2026.
  • Spruce Biosciences made up ﹤0.01% of Royal Bank of Canada's portfolio in Q2 2026, its #6808 holding.
  • Royal Bank of Canada first reported a position in Spruce Biosciences in Q4 2020 and has held it in 16 quarters since.
  • Royal Bank of Canada's Spruce Biosciences position peaked at $208K in Q1 2023.
  • 57 funds tracked by Wall St. Rank held Spruce Biosciences as of Q2 2026.

Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.